The Traderszone Network

Published in TZ Latest News 27 March, 2017 by The TZ Newswire Staff

AstraZeneca’s Lung Cancer Drug Secures China Approval (AZN)

Tagrisso becomes first drug from AstraZeneca to be approved under China’s new Priority Review pathway.